Who makes [18F] MNI-946?

[18F] MNI-946 is developed by Invicro.

Last reviewed 2026-04-19 · How we verify

[18F] MNI-946

Invicro · Phase 1 active Small molecule

At a glance

Generic name	[18F] MNI-946
Also known as	[18F]MK6240
Sponsor	Invicro
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[18F] MNI-946 CI brief — competitive landscape report
[18F] MNI-946 updates RSS · CI watch RSS
Invicro portfolio CI